TCTC Holdings’s Edwards Lifesciences EW Stock Holding History

TCTC Holdings’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-70	Closed	-$6.69K	–	554
2024 Q1	$6.69K	Buy	+70	New	+$5.88K	﹤0.01%	460
2023 Q3	–	Sell	-1,200	Closed	-$113K	–	455
2023 Q2	$113K	Hold	1,200	–	–	﹤0.01%	221
2023 Q1	$99.3K	Hold	1,200	–	–	﹤0.01%	240
2022 Q4	$89.5K	Hold	1,200	–	–	﹤0.01%	231
2022 Q3	$99K	Hold	1,200	–	–	﹤0.01%	215
2022 Q2	$114K	Hold	1,200	–	–	0.01%	213
2022 Q1	$141K	Hold	1,200	–	–	0.01%	211
2021 Q4	$155K	Hold	1,200	–	–	0.01%	220
2021 Q3	$136K	Hold	1,200	–	–	0.01%	215
2021 Q2	$124K	Hold	1,200	–	–	0.01%	210
2021 Q1	$100K	Hold	1,200	–	–	﹤0.01%	227
2020 Q4	$109K	Hold	1,200	–	–	0.01%	205
2020 Q3	$96K	Hold	1,200	–	–	0.01%	205
2020 Q2	$83K	Buy	+1,200	New	+$85.3K	﹤0.01%	210

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

TCTC Holdings's EW Position: Q2 2024 in Review

TCTC Holdings sold out of Edwards Lifesciences (EW) in Q2 2024, closing a stake of 70 shares — an estimated $6.69K sold.

TCTC Holdings first reported a position in EW in Q2 2020 and held it in 14 quarters. The position peaked at $155K in Q4 2021. 1,297 funds tracked by Wall St. Rank hold EW as of Q2 2024.

TCTC Holdings reported no remaining Edwards Lifesciences position as of Q2 2024 after selling out during the quarter.
TCTC Holdings sold 70 Edwards Lifesciences shares in Q2 2024, an estimated $6.69K.
TCTC Holdings first reported a position in Edwards Lifesciences in Q2 2020 and held it in 14 quarters.
TCTC Holdings's Edwards Lifesciences position peaked at $155K in Q4 2021.
1,297 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2024.

Based on TCTC Holdings's 13F filing for Q2 2024, filed 6 Aug 2024.